Title : Kadsurenone is a useful and promising treatment strategy for breast cancer bone metastases by blocking the PAF/PTAFR signaling pathway.

Pub. Date : 2018 Aug

PMID : 30008927






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Kadsurenone is a useful and promising treatment strategy for breast cancer bone metastases by blocking the PAF/PTAFR signaling pathway. kadsurenone platelet activating factor receptor Homo sapiens
2 Platelet-activating factor (PAF) is a potent phospholipid mediator, which has previously reported biological activities in BC progression and osteoclast differentiation by activating its receptor PAF receptor (PTAFR). Phospholipids platelet activating factor receptor Homo sapiens
3 It was further demonstrated that the natural PAF antagonist Kadsurenone may effectively attenuate each process by partially blocking the PAF/PTAFR signaling pathway. kadsurenone platelet activating factor receptor Homo sapiens
4 Therefore, targeting PAF/PTAFR by Kadsurenone may be a promising treatment strategy for BC bone metastases. kadsurenone platelet activating factor receptor Homo sapiens